Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Enlist Duo Probe To Look Into Whether Dow Withheld Safety Information December 14, 2015 Irvin Jackson Add Your Comments Following a recent decision to withdraw approval of the herbicide Enlist Duo, federal investigators are probing whether Dow Chemical Co. violated the law by not disclosing that the controversial chemicals glyphosate and 2,4-D become more potent when mixed together.ย The head of the U.S. Environmental Protection Agency (EPA) Office of Chemical Safety and Pollution Prevention, Jim Jones, indicated in a recent report by Bloomberg BNA that the agency’s enforcement division will open an investigation into Dow’s activities involving Enlist Duo, which contains the herbicide glyphosate that is also found in Roundup and has recently been linked to a potential risk of cancer. At issue in this investigation is the EPA’s recent discovery that Dow made claims of a “synergistic” effect between glyphosate and 2,4-D, which could make the two chemicals more toxic. The information was discovered in patent documents, but the EPA claims Dow never informed the agency that the two could become more powerful, and potentially more dangerous, when combined. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The EPA indicates that it contacted Dow after discovering the synergism claims, and warned the company that this would assess how the regulators factored the potential impacts to non-target organisms. Dow responded with more data, which the EPA is still reviewing. However, the preliminary findings led EPA reviewers to conclude that a 30-foot buffer it required around application areas for Enlist Duo may be insufficient. Glyphosate is most well-known as the active ingredient in Monsantoโs weed killer Roundup, which has been the subject of it’s own serious safety concerns in recent months, including indications that exposure to Roundup may cause cancer for humans. In March, the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC) determined that glyphosate is a probable carcinogen, which has led some countries to ban Roundup and other glyphosate-based pesticides. Monsanto now faces a growing number of Roundup cancer lawsuits filed on behalf of farm workers and others heavily exposed to glyphosate, indicating that they developed non-Hodgkin lymphoma or other cancers as a result of the manufacturer’s failure to adequately warn about the risks associated with the herbicide. The chemical 2,4-D was used in Agent Orange, a defoliant during the Vietnam War, which has been linked to a number of illnesses afflicting veterans of the war. According to the EPA, when it first reviewed the available data on Enlist Duo, it determined that there were no indications of synergism between the two chemicals that affected mammals or fish. Jones reportedly told Bloomberg he has asked EPA enforcement officials to look at whether Dow violated part of the Federal Insecticide, Fungicide and Rodenticide Act, which requires the EPA be notified when pesticide manufacturers discover new environmental effects involving their products. The EPA made its request to remove approval of Enlist Duo in a brief filed on November 24 as part of an ongoing lawsuit against the EPA brought by the Natural Resources Defense Council, a powerful environmental advocacy group, which is one of the leading critics indicating that the EPA’s decision to approve Enlist Duo in 2014 was based on flawed science. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Chemicals, Dow, Enlist Duo, Glyphosate, Herbicide, Roundup More Roundup Lawsuit Stories Judge Grants Preliminary Approval to Roundup Lawsuit Settlement Plan March 5, 2026 $7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits February 18, 2026 Roundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge February 9, 2026 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Chemotherapy Injection Port Lawsuit Blames AngioDynamics SmartPort for Wrongful Death (Posted: yesterday) An infection caused by an AngioDynamics SmartPort port catheter led to the death of a woman who contracted an infection only one month after receiving the implant. MORE ABOUT: ANGIODYNAMICS PORT CATHETER LAWSUITPort Catheter Lawyers Outline Process for Selecting Bellwether Lawsuits in AngioDynamics MDL (03/06/2026)Port Catheter Blood Clot Results in Lawsuit Against Device Manufacturer (02/04/2026)SmartPort Infection Lawsuit Alleges AngioDynamics Catheter Defects Forced Surgical Removal (01/30/2026) Lawyers To Nominate Hair Relaxer Cancer Cases for Early Bellwether Trials Next Week (Posted: 2 days ago) Plaintiffs and defendants involved in hair relaxer cancer lawsuits are expected to turn in a list of 12 cases that the parties believe are fit to serve as bellwether trials. MORE ABOUT: HAIR RELAXER LAWSUITCourt Outlines Procedures When Women Die After Filing a Hair Relaxer Cancer Lawsuit (02/25/2026)Hair Extension Chemicals May Be More Harmful Than Previously Thought: Study (02/17/2026)MDL Judge Issues New Deadlines for Hair Relaxer Lawsuit Bellwether Trial Preparations (02/04/2026) Cartiva Implant Recall Lawsuits Move Forward, as Plaintiffs Seek Compensation for Big Toe Surgery Failures (Posted: 3 days ago) Cartiva implant lawsuits are moving forward in federal court as patients across the United States seek compensation for complications linked to the recalled big toe device. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Synthetic Cartilage Implant Lawsuits Centralized in Federal MDL (02/10/2026)Lawsuit Alleges Cartiva Implant Loosened, Degraded in Great Toe (02/05/2026)Big Toe Fusion Lawsuit Filed Over Failed Cartiva SCI Implant (01/27/2026)
$7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits February 18, 2026
Roundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge February 9, 2026
Chemotherapy Injection Port Lawsuit Blames AngioDynamics SmartPort for Wrongful Death (Posted: yesterday) An infection caused by an AngioDynamics SmartPort port catheter led to the death of a woman who contracted an infection only one month after receiving the implant. MORE ABOUT: ANGIODYNAMICS PORT CATHETER LAWSUITPort Catheter Lawyers Outline Process for Selecting Bellwether Lawsuits in AngioDynamics MDL (03/06/2026)Port Catheter Blood Clot Results in Lawsuit Against Device Manufacturer (02/04/2026)SmartPort Infection Lawsuit Alleges AngioDynamics Catheter Defects Forced Surgical Removal (01/30/2026)
Lawyers To Nominate Hair Relaxer Cancer Cases for Early Bellwether Trials Next Week (Posted: 2 days ago) Plaintiffs and defendants involved in hair relaxer cancer lawsuits are expected to turn in a list of 12 cases that the parties believe are fit to serve as bellwether trials. MORE ABOUT: HAIR RELAXER LAWSUITCourt Outlines Procedures When Women Die After Filing a Hair Relaxer Cancer Lawsuit (02/25/2026)Hair Extension Chemicals May Be More Harmful Than Previously Thought: Study (02/17/2026)MDL Judge Issues New Deadlines for Hair Relaxer Lawsuit Bellwether Trial Preparations (02/04/2026)
Cartiva Implant Recall Lawsuits Move Forward, as Plaintiffs Seek Compensation for Big Toe Surgery Failures (Posted: 3 days ago) Cartiva implant lawsuits are moving forward in federal court as patients across the United States seek compensation for complications linked to the recalled big toe device. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Synthetic Cartilage Implant Lawsuits Centralized in Federal MDL (02/10/2026)Lawsuit Alleges Cartiva Implant Loosened, Degraded in Great Toe (02/05/2026)Big Toe Fusion Lawsuit Filed Over Failed Cartiva SCI Implant (01/27/2026)